IMI2 ha publicat els topics que té previst incloure en futures convocatòries:

• Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD)
• Fairification of IMI and EFPIA data
• Development of sensitive and validated clinical endpoints in primary Sjögren’s syndrome (PSS)
• European screening centre: unique library for attractive biology

Podeu trobar la descripció d’aquests topics al lloc web d'IMI2.